Last 12 months
Inside the activity.
1 purchase rows · 2632 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 142 |
| Dec 2025 | 0 | 143 |
| Jan 2026 | 0 | 78 |
| Feb 2026 | 0 | 26 |
| Mar 2026 | 0 | 364 |
| Apr 2026 | 0 | 346 |
| May 2026 | 1 | 340 |
| Jun 2026 | 0 | 298 |
| Jul 2026 | 0 | 240 |
| Aug 2026 | 0 | 251 |
| Sep 2026 | 0 | 260 |
| Oct 2026 | 0 | 144 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 26, 2024 Filed Mar 27, 2024 20:30 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 496 | $246.46 | $122,244.31 |
DisclosureSEC source: 0001415889-24-009206 · form4-03272024_040301.xml · nonDerivative · entry 13 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,490 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024. F11 · price: This transaction was executed in multiple trades at prices ranging from $246.005 to $246.93. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 26, 2024 Filed Mar 27, 2024 20:30 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 144 | $244.67 | $35,232.48 |
DisclosureSEC source: 0001415889-24-009206 · form4-03272024_040301.xml · nonDerivative · entry 12 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,986 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024. Read SEC document |
| March 26, 2024 Filed Mar 27, 2024 20:30 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
Exercise / conversionCommon Stock | 15,000 | $129.49 | $1,942,350.00 |
DisclosureSEC source: 0001415889-24-009206 · form4-03272024_040301.xml · nonDerivative · entry 11 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,130 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 20:30 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
Exercise / conversionStock Options · Derivative | 15,000 | $0.00 Strike: $129.49 | $0.00 |
DisclosureSEC source: 0001415889-24-009206 · form4-03272024_040301.xml · derivative · entry 18 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 491,654 Underlying: Common Stock · 15,000 shares Expires 2024-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 20:30 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 603 | $248.49 | $149,837.12 |
DisclosureSEC source: 0001415889-24-009206 · form4-03272024_040301.xml · nonDerivative · entry 10 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 130 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024. F10 · price: This transaction was executed in multiple trades at prices ranging from $248.325 to $248.535. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 20:30 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 829 | $247.59 | $205,250.20 |
DisclosureSEC source: 0001415889-24-009206 · form4-03272024_040301.xml · nonDerivative · entry 9 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 733 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024. F9 · price: This transaction was executed in multiple trades at prices ranging from $247.26 to $248.22. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 20:30 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 509 | $246.57 | $125,503.98 |
DisclosureSEC source: 0001415889-24-009206 · form4-03272024_040301.xml · nonDerivative · entry 8 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,562 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024. F8 · price: This transaction was executed in multiple trades at prices ranging from $246.235 to $247.025. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 20:30 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 502 | $244.88 | $122,931.07 |
DisclosureSEC source: 0001415889-24-009206 · form4-03272024_040301.xml · nonDerivative · entry 7 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,071 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024. F7 · price: This transaction was executed in multiple trades at prices ranging from $244.62 to $245.19. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 20:30 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 2,924 | $243.90 | $713,173.54 |
DisclosureSEC source: 0001415889-24-009206 · form4-03272024_040301.xml · nonDerivative · entry 6 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,573 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024. F6 · price: This transaction was executed in multiple trades at prices ranging from $243.55 to $244.50. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 20:30 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 4,252 | $243.09 | $1,033,636.54 |
DisclosureSEC source: 0001415889-24-009206 · form4-03272024_040301.xml · nonDerivative · entry 5 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,497 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024. F5 · price: This transaction was executed in multiple trades at prices ranging from $242.55 to $243.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 20:30 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 3,421 | $242.12 | $828,284.31 |
DisclosureSEC source: 0001415889-24-009206 · form4-03272024_040301.xml · nonDerivative · entry 4 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,749 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024. F4 · price: This transaction was executed in multiple trades at prices ranging from $241.53 to $242.52. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 20:30 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 1,492 | $241.05 | $359,651.08 |
DisclosureSEC source: 0001415889-24-009206 · form4-03272024_040301.xml · nonDerivative · entry 3 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,170 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024. F3 · price: This transaction was executed in multiple trades at prices ranging from $240.53 to $241.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 20:30 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 468 | $239.60 | $112,132.80 |
DisclosureSEC source: 0001415889-24-009206 · form4-03272024_040301.xml · nonDerivative · entry 2 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,662 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024. F2 · price: This transaction was executed in multiple trades at prices ranging from $239.32 to $240.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 20:30 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
Exercise / conversionCommon Stock | 15,000 | $129.49 | $1,942,350.00 |
DisclosureSEC source: 0001415889-24-009206 · form4-03272024_040301.xml · nonDerivative · entry 1 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,130 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024. Read SEC document |
| March 22, 2024 Filed Mar 25, 2024 20:30 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
Exercise / conversionStock Options · Derivative | 15,000 | $0.00 Strike: $129.49 | $0.00 |
DisclosureSEC source: 0001415889-24-009034 · form4-03252024_040302.xml · derivative · entry 13 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 506,654 Underlying: Common Stock · 15,000 shares Expires 2024-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024. Read SEC document |
| March 22, 2024 Filed Mar 25, 2024 20:30 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 3,661 | $238.29 | $872,394.33 |
DisclosureSEC source: 0001415889-24-009034 · form4-03252024_040302.xml · nonDerivative · entry 11 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 130 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024. F10 · price: This transaction was executed in multiple trades at prices ranging from $238.01 to $238.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 22, 2024 Filed Mar 25, 2024 20:30 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 5,212 | $237.56 | $1,238,162.72 |
DisclosureSEC source: 0001415889-24-009034 · form4-03252024_040302.xml · nonDerivative · entry 10 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,791 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024. F9 · price: This transaction was executed in multiple trades at prices ranging from $237.15 to $238.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 22, 2024 Filed Mar 25, 2024 20:30 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 3,612 | $236.62 | $854,665.66 |
DisclosureSEC source: 0001415889-24-009034 · form4-03252024_040302.xml · nonDerivative · entry 9 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,003 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024. F8 · price: This transaction was executed in multiple trades at prices ranging from $236.09 to $237.08. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 22, 2024 Filed Mar 25, 2024 20:30 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 735 | $235.34 | $172,975.86 |
DisclosureSEC source: 0001415889-24-009034 · form4-03252024_040302.xml · nonDerivative · entry 8 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,615 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024. F7 · price: This transaction was executed in multiple trades at prices ranging from $235.02 to $235.81. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 22, 2024 Filed Mar 25, 2024 20:30 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 1,780 | $234.62 | $417,624.13 |
DisclosureSEC source: 0001415889-24-009034 · form4-03252024_040302.xml · nonDerivative · entry 7 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,350 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024. F6 · price: This transaction was executed in multiple trades at prices ranging from $234.02 to $235.015. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 22, 2024 Filed Mar 25, 2024 20:30 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
Exercise / conversionCommon Stock | 15,000 | $129.49 | $1,942,350.00 |
DisclosureSEC source: 0001415889-24-009034 · form4-03252024_040302.xml · nonDerivative · entry 6 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,130 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024. Read SEC document |
| March 21, 2024 Filed Mar 22, 2024 20:30 UTC |
MAHON PAUL AEVP & GENERAL COUNSEL
|
Exercise / conversionStock Options · Derivative | 6,000 | $0.00 Strike: $117.76 | $0.00 |
DisclosureSEC source: 0001415889-24-008956 · form4-03222024_040310.xml · derivative · entry 6 MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,000 Underlying: Common Stock · 6,000 shares Expires 2027-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| March 21, 2024 Filed Mar 22, 2024 20:30 UTC |
MAHON PAUL AEVP & GENERAL COUNSEL
|
SaleCommon Stock | 1,400 | $237.36 | $332,304.14 |
DisclosureSEC source: 0001415889-24-008956 · form4-03222024_040310.xml · nonDerivative · entry 5 MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,710 F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. F6 · price: This transaction was executed in multiple trades at prices ranging from $237.22 to $237.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 21, 2024 Filed Mar 22, 2024 20:30 UTC |
MAHON PAUL AEVP & GENERAL COUNSEL
|
SaleCommon Stock | 3,505 | $236.71 | $829,683.62 |
DisclosureSEC source: 0001415889-24-008956 · form4-03222024_040310.xml · nonDerivative · entry 4 MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,110 F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. F5 · price: This transaction was executed in multiple trades at prices ranging from $236.20 to $237.195. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 21, 2024 Filed Mar 22, 2024 20:30 UTC |
MAHON PAUL AEVP & GENERAL COUNSEL
|
SaleCommon Stock | 238 | $235.73 | $56,104.17 |
DisclosureSEC source: 0001415889-24-008956 · form4-03222024_040310.xml · nonDerivative · entry 3 MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 41,615 F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. F4 · price: This transaction was executed in multiple trades at prices ranging from $235.16 to $236.15. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 21, 2024 Filed Mar 22, 2024 20:30 UTC |
MAHON PAUL AEVP & GENERAL COUNSEL
|
SaleCommon Stock | 857 | $234.11 | $200,634.07 |
DisclosureSEC source: 0001415889-24-008956 · form4-03222024_040310.xml · nonDerivative · entry 2 MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 41,853 F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. F3 · price: This transaction was executed in multiple trades at prices ranging from $233.74 to $234.33. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 21, 2024 Filed Mar 22, 2024 20:30 UTC |
MAHON PAUL AEVP & GENERAL COUNSEL
|
Exercise / conversionCommon Stock | 6,000 | $117.76 | $706,560.00 |
DisclosureSEC source: 0001415889-24-008956 · form4-03222024_040310.xml · nonDerivative · entry 1 MAHON PAUL A · CIK 0001231589 · EVP & GENERAL COUNSEL 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,710 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. F2 · balance_after: Includes 118 shares acquired on March 4, 2024, under the United Therapeutics Corporation Employee Stock Purchase Plan. Read SEC document |
| March 21, 2024 Filed Mar 25, 2024 20:30 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
Exercise / conversionStock Options · Derivative | 15,000 | $0.00 Strike: $129.49 | $0.00 |
DisclosureSEC source: 0001415889-24-009034 · form4-03252024_040302.xml · derivative · entry 12 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 521,654 Underlying: Common Stock · 15,000 shares Expires 2024-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024. Read SEC document |
| March 21, 2024 Filed Mar 25, 2024 20:30 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 2,497 | $237.38 | $592,739.86 |
DisclosureSEC source: 0001415889-24-009034 · form4-03252024_040302.xml · nonDerivative · entry 5 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 130 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024. F5 · price: This transaction was executed in multiple trades at prices ranging from $237.10 to $237.88. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 21, 2024 Filed Mar 25, 2024 20:30 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 8,650 | $236.57 | $2,046,346.94 |
DisclosureSEC source: 0001415889-24-009034 · form4-03252024_040302.xml · nonDerivative · entry 4 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,627 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024. F4 · price: This transaction was executed in multiple trades at prices ranging from $236.085 to $237.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 21, 2024 Filed Mar 25, 2024 20:30 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 2,500 | $235.58 | $588,956.75 |
DisclosureSEC source: 0001415889-24-009034 · form4-03252024_040302.xml · nonDerivative · entry 3 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,277 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024. F3 · price: This transaction was executed in multiple trades at prices ranging from $235.07 to $236.065. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 21, 2024 Filed Mar 25, 2024 20:30 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 1,353 | $234.38 | $317,114.79 |
DisclosureSEC source: 0001415889-24-009034 · form4-03252024_040302.xml · nonDerivative · entry 2 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,777 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024. F2 · price: This transaction was executed in multiple trades at prices ranging from $234.03 to $235.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 21, 2024 Filed Mar 25, 2024 20:30 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
Exercise / conversionCommon Stock | 15,000 | $129.49 | $1,942,350.00 |
DisclosureSEC source: 0001415889-24-009034 · form4-03252024_040302.xml · nonDerivative · entry 1 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,130 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024. Read SEC document |
| March 20, 2024 Filed Mar 21, 2024 20:30 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
Exercise / conversionStock Options · Derivative | 15,000 | $0.00 Strike: $129.49 | $0.00 |
DisclosureSEC source: 0001415889-24-008841 · form4-03212024_040301.xml · derivative · entry 16 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 536,654 Underlying: Common Stock · 15,000 shares Expires 2024-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024. Read SEC document |
| March 20, 2024 Filed Mar 21, 2024 20:30 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 150 | $238.28 | $35,742.00 |
DisclosureSEC source: 0001415889-24-008841 · form4-03212024_040301.xml · nonDerivative · entry 14 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 130 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024. Read SEC document |
| March 20, 2024 Filed Mar 21, 2024 20:30 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 2,863 | $237.21 | $679,129.08 |
DisclosureSEC source: 0001415889-24-008841 · form4-03212024_040301.xml · nonDerivative · entry 13 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 280 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024. F12 · price: This transaction was executed in multiple trades at prices ranging from $236.875 to $237.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 20, 2024 Filed Mar 21, 2024 20:30 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 6,055 | $236.37 | $1,431,224.59 |
DisclosureSEC source: 0001415889-24-008841 · form4-03212024_040301.xml · nonDerivative · entry 12 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,143 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024. F11 · price: This transaction was executed in multiple trades at prices ranging from $235.885 to $236.865. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 20, 2024 Filed Mar 21, 2024 20:30 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 3,642 | $235.19 | $856,560.89 |
DisclosureSEC source: 0001415889-24-008841 · form4-03212024_040301.xml · nonDerivative · entry 11 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,198 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024. F10 · price: This transaction was executed in multiple trades at prices ranging from $234.88 to $235.81. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 20, 2024 Filed Mar 21, 2024 20:30 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 2,290 | $234.33 | $536,616.62 |
DisclosureSEC source: 0001415889-24-008841 · form4-03212024_040301.xml · nonDerivative · entry 10 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,840 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024. F9 · price: This transaction was executed in multiple trades at prices ranging from $233.855 to $234.845. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 20, 2024 Filed Mar 21, 2024 20:30 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
Exercise / conversionCommon Stock | 15,000 | $129.49 | $1,942,350.00 |
DisclosureSEC source: 0001415889-24-008841 · form4-03212024_040301.xml · nonDerivative · entry 9 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,130 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024. Read SEC document |
| March 19, 2024 Filed Mar 21, 2024 20:30 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
Exercise / conversionStock Options · Derivative | 15,000 | $0.00 Strike: $129.49 | $0.00 |
DisclosureSEC source: 0001415889-24-008841 · form4-03212024_040301.xml · derivative · entry 15 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 551,654 Underlying: Common Stock · 15,000 shares Expires 2024-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024. Read SEC document |
| March 19, 2024 Filed Mar 21, 2024 20:30 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 1,653 | $239.30 | $395,562.07 |
DisclosureSEC source: 0001415889-24-008841 · form4-03212024_040301.xml · nonDerivative · entry 8 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 130 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024. F8 · price: This transaction was executed in multiple trades at prices ranging from $239.17 to $239.43. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 19, 2024 Filed Mar 21, 2024 20:30 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 2,825 | $238.48 | $673,713.91 |
DisclosureSEC source: 0001415889-24-008841 · form4-03212024_040301.xml · nonDerivative · entry 7 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,783 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024. F7 · price: This transaction was executed in multiple trades at prices ranging from $238.13 to $239.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 19, 2024 Filed Mar 21, 2024 20:30 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 2,953 | $237.08 | $700,100.19 |
DisclosureSEC source: 0001415889-24-008841 · form4-03212024_040301.xml · nonDerivative · entry 6 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,608 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024. F6 · price: This transaction was executed in multiple trades at prices ranging from $236.66 to $237.59. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 19, 2024 Filed Mar 21, 2024 20:30 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 2,958 | $236.28 | $698,918.90 |
DisclosureSEC source: 0001415889-24-008841 · form4-03212024_040301.xml · nonDerivative · entry 5 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,561 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024. F5 · price: This transaction was executed in multiple trades at prices ranging from $235.66 to $236.65. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 19, 2024 Filed Mar 21, 2024 20:30 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 2,409 | $235.08 | $566,300.01 |
DisclosureSEC source: 0001415889-24-008841 · form4-03212024_040301.xml · nonDerivative · entry 4 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,519 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024. F4 · price: This transaction was executed in multiple trades at prices ranging from $234.635 to $235.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 19, 2024 Filed Mar 21, 2024 20:30 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 975 | $233.98 | $228,128.45 |
DisclosureSEC source: 0001415889-24-008841 · form4-03212024_040301.xml · nonDerivative · entry 3 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,928 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024. F3 · price: This transaction was executed in multiple trades at prices ranging from $233.60 to $234.59. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 19, 2024 Filed Mar 21, 2024 20:30 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
SaleCommon Stock | 1,227 | $233.25 | $286,198.85 |
DisclosureSEC source: 0001415889-24-008841 · form4-03212024_040301.xml · nonDerivative · entry 2 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,903 F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024. F2 · price: This transaction was executed in multiple trades at prices ranging from $232.57 to $233.565. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 19, 2024 Filed Mar 21, 2024 20:30 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
Exercise / conversionCommon Stock | 15,000 | $129.49 | $1,942,350.00 |
DisclosureSEC source: 0001415889-24-008841 · form4-03212024_040301.xml · nonDerivative · entry 1 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,130 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024. Read SEC document |
| March 18, 2024 Filed Mar 19, 2024 20:30 UTC |
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
|
Exercise / conversionStock Options · Derivative | 15,000 | $0.00 Strike: $129.49 | $0.00 |
DisclosureSEC source: 0001415889-24-008529 · form4-03192024_040301.xml · derivative · entry 14 ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 566,654 Underlying: Common Stock · 15,000 shares Expires 2024-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.